15 Feb 2022 , 08:50 AM
Net profit of Sandu Pharmaceuticals rose 55.17% to Rs 0.45 crore in the quarter ended December 2021 as against Rs 0.29 crore during the previous quarter ended December 2020. Sales rose 21.43% to Rs 19.15 crore in the quarter ended December 2021 as against Rs 15.77 crore during the previous quarter ended December 2020.
Particulars | Quarter Ended | ||
? | Dec. 2021 | Dec. 2020 | % Var. |
Sales | 19.15 | 15.77 | 21 |
OPM % | 4.02 | 3.11 | – |
PBDT | 0.77 | 0.55 | 40 |
PBT | 0.64 | 0.41 | 56 |
NP | 0.45 | 0.29 | 55 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.